Key facts
- It has raised $1.2M; the latest was Seed Round ($1.2M) in Oct 2025.
- Notable investors include Plug and Play Tech Center, Transpose Platform Management, Entrepreneurs First, Tiny Supercomputer Investment Company, Arben Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Genie Fertility
- ·The full record, as it builds
Funding rounds
No funding rounds for Genie Fertility are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Genie Fertility
Developer of reproductive health diagnostics designed to advance understanding of fertility and uterine health. The company's platform offers molecular biomarker discovery, advanced analytics for reproductive health assessment, integration with clinical workflows, and data-driven insights, enabling healthcare providers and researchers focused on fertility to access precise diagnostic tools, improve patient outcomes, and support evidence-based reproductive care.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2024
- Employees
- 6
- Website
- geniefertility.com/
- Ownership
- Privately Held (backing)
Genie Fertility doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Genie Fertility shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Genie Fertility in its N-PORT filings yet. We sweep new filings monthly.